Listen as we discuss new CDER leadership, how CDER & CBER will collaborate to bring more consistency to reviews, and the action we took on HRT this week.
--------
29:58
--------
29:58
FDA Direct: Removing Black Box Warnings for HRT (Part 2/2)
Practicing doctors share their perspectives on the use of HRT for menopausal women and the FDA's action to remove boxed warnings.
--------
42:04
--------
42:04
FDA Direct: Removing Black Box Warnings for HRT (Part 1/2)
Learn more about why the FDA is initiating label changes for hormone replacement therapy products for menopausal women.
--------
1:11:20
--------
1:11:20
FDA Direct: Dramatically lowering drug prices for Americans
Biologic drugs are incredible, but they’re expensive – and they account for 51% of all drug spending. How can we bring cheaper alternatives to market?
--------
20:15
--------
20:15
FDA Direct: Who Buys the Spin — Hook, Line and Sinker?
It’s amusing when reporters and writers do not have access to FDA information on manufacturing and sterility violations — yet make calls from the peanut gallery.
Commissioner Makary and other members of FDA leadership, as well as guests, engage in timely and frank discussions to bring you an inside look at the current happenings at the FDA.